APR 20, 2019 8:41 PM PDT

Underwater Forest May Bring New Therapeutics

WRITTEN BY: Nouran Amin

Microbes that produce defensive compounds have contributed to the major source of antibiotics and other therapeutics. However, due to the rise of antibiotic-resistant bacteria, researchers are now seeking new drug candidates offshore.

Currently, a family of sea-dwelling bacteria known as Actinobacteria have helped in producing new antibiotics with their rich source of bioactive microbial compounds. Now a study published in Frontiers in Microbiology, revealed that an underwater species of seaweed, called Laminaria ochroleuca, serves as a rich source of bacteria with antimicrobial and anticancer compounds--the discovery can lead to new therapeutics.

"About half of the 20,000+ microbe-derived drug candidates currently known come from Actinobacteria," says senior study author Dr. Maria de Fátima Carvalho of the Interdisciplinary Center of Marine and Environmental Research (CIIMAR), Portugal. "Now the supply of new species on land -- where they form spores and branched networks just like a fungus -- is beginning to run out. Several novel drug leads derived from marine Actinobacteria are already known. These include anticancer agent salinosporamide A, currently in clinical trials, and several new antibiotics that are effective against drug-resistant infections like MRSA and tuberculosis."

The study showed that extracts of the seaweed L. ochroleuca is a rich source of Actinobacteria with promising antimicrobial and anticancer activities.

"The brown alga Laminaria ochroleuca forms complex structures called kelp forests, which are among the most diverse and productive ecosystems in the world," says Carvalho. "But until now, no-one had characterized the Actinobacteria that live inside L. ochroleuca. Seven of the extracts inhibited growth of breast and particularly nerve cell cancers, while having no effect on non-cancer cells."

Kelp forests are among the most diverse and productive ecosystems in the world. Image: Shutterstock.

"We identified extracts from two Actinobacteria strains that do not match any known compounds in the most comprehensive international database of natural bioactive compounds. We intend to follow up on these exciting results."

Source: Frontiers

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
DEC 08, 2019
Genetics & Genomics
DEC 08, 2019
Finding a Way to Treat Dangerous Protein Aggregates
The scientists are hopeful that this work will lead to new therapeutics for neurodegenerative disease....
DEC 17, 2019
Cell & Molecular Biology
DEC 17, 2019
A New Tool for Assessing the Impact of Drugs on Single Cells
When scientists assess the impact of a treatment like a drug on cells, they usually generally rely on large populations of cells to find general trends....
JAN 20, 2020
Cell & Molecular Biology
JAN 20, 2020
Using Modified Red Blood Cells As a Drug Delivery System
For a drug to be effective, it has to get to the right place to exert its impact....
FEB 04, 2020
Cancer
FEB 04, 2020
The role of SRR in colorectal cancer
Researchers from Osaka University have recently discovered a new function of the multifunctional enzyme entitled serine racemase (SRR). According to the te...
FEB 13, 2020
Cell & Molecular Biology
FEB 13, 2020
Study of Early-Onset Parkinson's Reveals Potential Therapeutic
Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising....
FEB 20, 2020
Drug Discovery & Development
FEB 20, 2020
Antibiotics for Superbug Infections?
Antibiotics for superbug infections? A study published in the Proceedings of the National Academy of Sciences claims that a combination of compounds can ta...
Loading Comments...